BIOVENTUS INC.
Last · NASDAQ$13.83-0.53 (-3.69%)close · yahoo · 8h ago
Market cap$944.66M68.3M sh
P/E · TTM17.7fwd 15.0 · eps 0.78
Beta0.65vs S&P 500
Div yield—annual · TTM
52w range
$6.255$15.89
Volume478.6Ksession
| Revenue | $285.3M |
|---|---|
| Operating income | $27.5M |
| Net income | $36.6M |
| Free cash flow | $27.3M |
| Operating margin | 9.7% |
| Net margin | 12.8% |
| Return on equity | 16.0% |
| Period | 2026 |
Loading chart…
Upcoming earnings
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
$0.16
Est. revenue
149.5M
Earnings transcripts
Press & signals
- GlobeNewswire
Bioventus Reports Second Quarter Financial Results